Incanthera (INC) was a spin-out from the Institute of Cancer Therapeutics (ICT) at the University of Bradford to exploit development opportunities generated by ICT. Following its listing on the Aquis Growth Exchange in February 2020, INC has been concentrating its resources on the further advancement of lead product, Sol, which is now the subject of progressive discussions with two global cosmetic companies. A recent oversubscribed Placing with institutional investors raised ca.£1.0m net and provides the group with a cash runway until the second half of calendar 2022, excluding any income which may be included as part of a licensing deal.

18 May 2021
Significant progress in first anniversary as plc

Sign up for free to access
Get access to the latest equity research in real-time from 12 commissioned providers.
Get access to the latest equity research in real-time from 12 commissioned providers.
Significant progress in first anniversary as plc
Incanthera Plc (INC:PLU) | 5.8 0 0.0% | Mkt Cap: 7.93m
- Published:
18 May 2021 -
Author:
Martin Hall -
Pages:
10 -
Incanthera (INC) was a spin-out from the Institute of Cancer Therapeutics (ICT) at the University of Bradford to exploit development opportunities generated by ICT. Following its listing on the Aquis Growth Exchange in February 2020, INC has been concentrating its resources on the further advancement of lead product, Sol, which is now the subject of progressive discussions with two global cosmetic companies. A recent oversubscribed Placing with institutional investors raised ca.£1.0m net and provides the group with a cash runway until the second half of calendar 2022, excluding any income which may be included as part of a licensing deal.